Muscle Growth Peptides

The Wolverine Stack is in this category: one vial holding BPC-157 and TB-500, with the amount of each shown on its product page. Blends draw regulatory attention: in August 2026 warning letters, FDA called two other sellers' blends unapproved new drugs, including one described as tesamorelin 10 mg plus ipamorelin 3 mg.³⁴ For prescription drugs, FDA allows a fixed combination only when each component contributes to the claimed effects and each component's dosage keeps the combination safe and effective for the patients its labeling defines.⁵ BPC-157 and TB-500 are also sold as single vials.

No source behind this page reports a trial of the pair for muscle growth, so this page makes no such claim. The record that does exist concerns sport and safety. WADA's 2027 Prohibited List, in force from January 1, 2027, still names CJC-1295 and ipamorelin in class S2.¹² The combined vial is CJC-1295 + Ipamorelin, listed outside the categories, and FDA's safety notes on each compound are summarized on growth hormone peptides.

FDA lists mechano growth factor (MGF) in 503A Category 3, which means it was nominated for pharmacy compounding without adequate support.⁶ A different, pegylated form, PEG-MGF, is on FDA's list of substances once in Category 2 whose nominations were withdrawn, and FDA says it has not identified any human exposure data on drug products that contain it.⁷ WADA's 2026 list bans mechano growth factors at all times as growth factors.⁸ The MGF education page covers the published research and its limits.